Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71]. uri icon

Overview

publication date

  • January 3, 2018

Identity

Scopus Document Identifier

  • 85039866578

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2017.12.016

PubMed ID

  • 29306512

Additional Document Info

volume

  • 73

issue

  • 4